CYB5B

CYB5B is a heme-dependent cytochrome b5 isoform anchored in the outer mitochondrial membrane that supplies electrons to multiple metabolic oxidoreductase systems (PMID:22203676, PMID:22178913). It is an essential, heme-dependent electron-transfer component of the mitochondrial mARC/MOSC N-reductase system, where—together with mARC1/mARC2 (MOSC1/MOSC2)—it reduces N-hydroxylated substrates; this role is specific to the mitochondrial CYB5B isoform and is not fulfilled by microsomal CYB5A, and is abolished when heme-free apo-CYB5B is substituted (PMID:22203676, PMID:23703616). Beyond N-reduction, CYB5B acts redundantly with CYB5A in sterol-C4 oxidation during cholesterol biosynthesis: loss of CYB5B blocks this step and causes accumulation of T-MAS and dihydro-T-MAS, which in turn inhibits the SREBP pathway and activates PPARγ signaling (PMID:39489939). CYB5B physically associates with fatty-acid metabolism machinery, interacting with Mitoregulin (MTLN) in a complex that also includes CPT1B at the outer mitochondrial membrane (PMID:37664623), and its enzyme system is metabolically responsive, with N-reductive activity modulated by fasting and high-fat diet (PMID:25144769). It also forms an entropy-driven complex with the mitochondrial cytochrome P450 CYP11A1 (PMID:28238672).

1. 2011 High

   Established which cytochrome b5 isoform and partner drive the amidoxime/N-reductase activity, resolving that this is a mitochondrial outer-membrane system rather than a microsomal one.

   Evidence siRNA knockdown of candidate components in differentiated 3T3-L1 adipocytes with amidoxime reductase activity assay and radiolabeled substrate binding to MOSC2

   PMID:22203676

   Open questions at the time

   • Identity of the CYB5B reductase partner not defined
   • Mechanism linking the system to impaired lipid synthesis not dissected
2. 2011 Medium

   Confirmed CYB5B's outer mitochondrial membrane localization by exploiting it as a surface marker for intact mitochondrial isolation.

   Evidence Immunomagnetic enrichment with anti-CYB5B antibody beads and Western blot validation across multiple mouse tissues and cell lines

   PMID:22178913

   Open questions at the time

   • Membrane topology and orientation not resolved here
   • Single-lab study
3. 2013 High

   Showed the N-reductive function is strictly isoform-specific (CYB5B not CYB5A) and absolutely dependent on the heme cofactor, defining the catalytic requirement.

   Evidence RNAi in HEK-293 and HepG2 cells, N-reductive biotransformation assays, heme-free apo-CYB5B reconstitution, and CYB5A knockout mice

   PMID:23703616

   Open questions at the time

   • Structural basis of electron transfer to mARC not resolved
   • Physiological endogenous substrates beyond xenobiotic N-hydroxy compounds unclear
4. 2014 Medium

   Linked the CYB5B/mARC N-reductase system to whole-body energy state, showing it is nutritionally regulated.

   Evidence qRT-PCR, Western blot, and N-reductive activity assays in mouse liver under fasting and high-fat diet, with in vivo benzamidoxime metabolite measurement

   PMID:25144769

   Open questions at the time

   • Regulation measured at mARC level, not directly at CYB5B
   • No independent replication
   • Mechanism of dietary regulation unknown
5. 2017 Medium

   Distinguished CYB5B's interaction mode with cytochrome P450 partners, showing it forms an entropy-driven, non-allosteric complex with mitochondrial CYP11A1 unlike microsomal CYB5A-CYP complexes.

   Evidence Surface Plasmon Resonance thermodynamic analysis of 18 CYB5-CYP pairs

   PMID:28238672

   Open questions at the time

   • No mutagenesis or functional validation of the CYB5B-CYP11A1 interaction
   • Functional consequence for steroidogenesis untested
6. 2023 Medium

   Placed CYB5B in a defined fatty-acid metabolism complex by identifying its physical association with MTLN and CPT1B at the outer mitochondrial membrane.

   Evidence Split-GFP topology reporters, co-immunoprecipitation, MTLN knockout mouse, and VLCFA metabolite measurement

   PMID:37664623

   Open questions at the time

   • Direct catalytic role of CYB5B in the MTLN complex not defined
   • Reciprocal interaction validation limited
   • Single lab
7. 2024 High

   Revealed a second, distinct biosynthetic role: CYB5B supplies electrons for sterol-C4 oxidation in cholesterol biosynthesis, acting redundantly with CYB5A and impacting SREBP/PPARγ signaling.

   Evidence CYB5B knockout HeLa cells, liver-specific Cyb5b knockout mice with combined Cyb5a knockdown, sterol metabolite profiling, and SREBP/PPARγ pathway analysis

   PMID:39489939

   Open questions at the time

   • Mechanism of redundancy/compensation between mitochondrial CYB5B and microsomal CYB5A unclear
   • Direct electron acceptor in C4 oxidation not specified
8. 2024 Low

   Correlated CYB5B with mitochondrial function and inflammatory signaling downstream of MTCH2 in an inflammation model.

   Evidence LPS-induced inflammation in periodontal ligament fibroblasts with Western blot, mitochondrial function readouts, and NF-κB/cytokine measurements

   PMID:39491029

   Open questions at the time

   • Correlative MTCH2-CYB5B relationship without direct mechanistic dissection
   • Single cell model, single lab
   • Causal role of CYB5B in inflammation not established

• The identity of the CYB5B-specific reductase that re-reduces its heme within each enzyme system, and the structural basis for partitioning between N-reduction, sterol oxidation, and fatty-acid complexes, remain unresolved.
• No structural model of CYB5B with mARC, CYP11A1, or MTLN complexes
• Reductase partner of CYB5B not definitively assigned
• Determinants of substrate/pathway selectivity unknown